Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23\
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control group | Placebo Comparator | During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (0g NnEx) per day with or after meals. |
|
| low concentration of NnEx group | Experimental | During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (1g NnEx) per day with or after meals. |
|
| high concentration of NnEx group | Experimental | During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (2g NnEx) per day with or after meals. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nelumbo nucifera Leaf Extract | Dietary Supplement | Hot water extracted Nelumbo nucifera Leaf, mainly containing quercetin and quercetin 3-O-glucuronide. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in anthropometrix indices during the study | weight in kilograms | baseline, 6 weeks, 12 weeks |
| Changes in anthropometrix indices during the study | height in meters | baseline, 6 weeks, 12 weeks |
| Changes in anthropometrix indices during the study | body fat in percentage | baseline, 6 weeks, 12 weeks |
| Changes in anthropometrix indices during the study | visceral fat in percentage | baseline, 6 weeks, 12 weeks |
| Changes in anthropometrix indices during the study | waist in centimeters | baseline, 6 weeks, 12 weeks |
| Changes in anthropometrix indices during the study | hip in centimeters | baseline, 6 weeks, 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in fasting biochemical indices during the study | glucose in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | HbA1c in mmol/L |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | TG in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | FFA in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | T-cho in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | HDL-cho in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | LDL-cho in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | ASP in mmol/L | baseline, 6 weeks, 12 weeks |
| Changes in fasting biochemical indices during the study | BUN in mmol/L | baseline, 6 weeks, 12 weeks |